Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
Notified -
Globe Newswire17-12-2024, 19:30
AquaSculpt Reviews (2025): Investigative Report Uncovers the Truth About This “Ice Water Hack” for Effortless Weight Loss 20-03-2025, 11:03